Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session on examining the interrelationship between the intellectual property provisions of the GATT treaty implementing law and food and drug law and its impact on the creation of new breakthrough drugs and production of lower generic copies and S. 1277, a bill to provide equitable relief for the generic drug industry, and for other purposes, February 27, and March 5, 1996
Author(s)
Bibliographic Information
Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session on examining the interrelationship between the intellectual property provisions of the GATT treaty implementing law and food and drug law and its impact on the creation of new breakthrough drugs and production of lower generic copies and S. 1277, a bill to provide equitable relief for the generic drug industry, and for other purposes, February 27, and March 5, 1996
（U.S. Congressional Committee Publications on GATT & WTO, 1949-1999）
Congressional Information Service, [2000?]
Microform（Microfiche）
Available at / 1 libraries
-
No Libraries matched.
- Remove all filters.
Search this Book/Journal
Note
Originally published: Washington : U.S. Government Printing Office, 1997
"S. Hrg. 104-878"
"Serial no. J-104-65"